Artemis is a multifunctional phospho-protein with roles in V(D)J recombination, repair of double-strand breaks by nonhomologous end-joining and regulation of cell-cycle checkpoints after DNA damage. Here, we describe a new function of Artemis as a negative regulator of p53 in response to oxidative stress in both primary cells and cancer cell lines. We show that depletion of Artemis under typical culture conditions (21% oxygen) leads to a spontaneous phosphorylation and stabilization of p53, and resulting cellular G1 arrest and apoptosis. These effects are suppressed by codepletion of DNA-PKcs, but not ATM, indicating that Artemis is an inhibitor of DNA-PKcs-mediated stabilization of p53. Culturing of cellsat 3% oxygen or treatment with an antioxidant abrogated p53 stabilization, indicating that oxidative stress is the responsible cellular stimulus. Treatment with ionizing radiation or hydrogen peroxide did not cause activation of this signaling pathway, whereas inhibitors of mitochondrial electron transport were effective in reducing its activation. In addition, we show that p53-inducible genes involved in reducing reactive oxygen species are upregulated by Artemis depletion. These findings indicate that Artemis and DNA-PKcs participate in a new, signaling pathway to modulate p53 function in response to oxidative stress produced by mitochondrial respiration.
Introduction
Artemis is a phospho-protein that seems to play multiple roles in mammalian cells. It is known to be required for V(D)J recombination and its functional loss causes a severe combined immunodeficiency (Moshous et al., 2000 (Moshous et al., , 2001 Ma et al., 2002; Rooney et al., 2002) . In addition, Artemisdeficient cells are radiosensitive and are defective in the repair of a minor fraction of double-strand breaks created by ionizing radiation (Riballo et al., 2004) . Artemis also has roles in cell-cycle regulation in response to DNA damage, as it has been proven to be a substrate of the phosphatidylinositol-3-OH kinase-like kinases (PIKKs) ATM (Ataxia telangiectasia mutated), ATR (ataxia-telangiectasia and Rad3-related) and DNA-PKcs (DNA-dependent protein kinase catalytic subunit) both in vitro and in vivo (Ma et al., 2002 (Ma et al., , 2005 Poinsignon et al., 2004; Riballo et al., 2004; Zhang et al., 2004; Chen et al., 2005; Wang et al., 2005; Geng et al., 2007) . Our earlier findings have also shown that it is involved in the recovery from the G2/M cell-cycle checkpoint by regulating the activation of Cdk2-cyclin B at the centrosome (Zhang et al., 2004; Geng et al., 2007) . We now show that Artemis also has a role in regulating the G1 phase of the cell cycle by acting as a negative regulator of p53.
The tumor suppressor p53 has well-established roles in mediating cell-cycle arrest, senescence and apoptosis in response to DNA damage; however, more recent findings indicate that it also has a role in regulating energy metabolism and oxidative stress (Karawajew et al., 2005; Bensaad and Vousden, 2007) . For example, p53 regulates a number of genes that are involved in either mitochondrial respiration (SCO2) or glycolysis (phosphoglycerate mutase) (Kondoh et al., 2005; Matoba et al., 2006) . In fact, disruption of p53 function may account for the Warburg effect, in which cancer cells switch toward glycolysis for energy production. The major source of ROS within cells is mitochondrial respiration; thus, the ability of p53 to regulate this process as well as glycolysis allows it to modulate the intracellular levels of ROS, and thus to control oxidative stress. However, the control of oxidative stress by p53 is complex as it positively regulates both antioxidant and pro-oxidant genes. Under low-stress conditions, antioxidant genes such as the sestrins, glutathione peroxidase and the aldehyde-4 family are all upregulated by p53 in order to reduce levels of ROS (Bensaad and Vousden, 2007) . In addition, p53 regulates the gene TIGAR (TP53-induced glycolysis and apoptosis regulator), which switches glucose consumption from glycolysis to an alternate pathway, resulting in production of NADPH, which is required for ROS scavenging by reduced glutathione (Bensaad et al., 2006) . Interestingly, p53 also positively regulates pro-oxidant genes such as PIG-3 and proline oxidase, and the aforementioned SCO2 gene, all of which act to increase intracellular ROS levels under high-stress conditions. Although many of the downstream targets of p53 in the regulation of oxidative stress have been characterized, the upstream regulation of p53 in response to oxidative stress is poorly understood. Our findings reported here help to clarify these pathways by showing that Artemis and DNA-PKcs function antagonistically to regulate the activation of p53 in response to oxidative stress derived from oxidative phosphorylation.
Results
Depletion of Artemis induces p53 accumulation, cell-cycle arrest and apoptosis Our earlier studies of Artemis have shown that it plays a role in cell-cycle checkpoint regulation after exposure of cells to DNA damage (Zhang et al., 2004; Geng et al., 2007) . During the course of these studies, we noted that depletion of Artemis by small interfering RNA (siRNA) caused an accumulation of U2OS cells in the G1 phase of the cell cycle whether or not cells were exposed to DNA damage (Figure 1a) . A similar result was also observed in HeLa cells (data not shown). As p53 is a well-established mediator of G1 arrest, we assessed whether p53 levels were altered by Artemis depletion. In both cancer cell lines and primary fibroblast cells (MRC-5) Artemis depletion induced upregulation and activation of p53, as indicated by the concomitant upregulation of p21 (Figure 1b) . Surprisingly, this accumulation of p53 also occurred in HeLa cells (Figure 1c ), which are typically unable to upregulate p53 because of the presence of the human papilloma virus (HPV) E6 protein, which mediates degradation of p53 through an associated E3 ubiquitin ligase (Scheffner et al., 1993) . A second cell line, termed SiHa (Seedorf et al., 1987) , which expresses the HPV E6 protein, also showed upregulation of p53 upon Artemis depletion (data not shown). Thus, Artemis depletion seems to stabilize p53 through a mechanism distinct from that induced by DNA damage. To show that the depletion of Artemis by this siRNA was specific, an Artemis construct refractory to the siRNA was shown to suppress the upregulation of p53 (Figure 1d ). To further validate this approach, we used five different siRNAs to target Artemis and monitored the changes in p53 levels. As shown (Figure 1e ), depletion of Artemis strongly statistically correlated with accumulation of p53, as indicated by regression analysis.
In addition to cell-cycle arrest, activated p53 also induces programmed cell death . We, therefore, examined markers of apoptosis after Artemis depletion. As shown, the pro-apoptotic gene Bax (Zhang et al., 2000) was upregulated ( Figure 2a) , and both PARP cleavage and sub-G1 cells were increased (Figures 2b and c) . Furthermore, simultaneous treatment with either of the spindle poisons, Taxol or nocodazole, significantly enhanced the level of apoptosis observed with Artemis depletion. To further confirm this phenotype, we examined p21 null cells (Waldman et al., 1995) for apoptosis mediated by Artemis depletion. Others have shown that in the absence of p21, apoptosis due to cellular stress is enhanced (Tian et al., 2000; Sohn et al., 2006) . In the absence of p21, Artemis-depleted HCT116 cells exhibited a significantly enhanced level of apoptosis (Figure 2d ), indicating that reduction in Artemis levels strongly induces programmed cell death.
Artemis depletion stabilizes p53 by DNA-PKcs-mediated phosphorylation We next examined whether Artemis depletion upregulated p53 by a transcriptional or post-translational mechanism. Knockdown of Artemis in HeLa cells did not alter the levels of p53 transcripts compared with control cells as determined by quantitative RT-PCR (Supplementary Figure S1 ). However, in the presence of the translational inhibitor cycloheximide, stabilization of p53 was observed with Artemis depletion by siRNA ( Figure 3a ). In the presence of the 26S proteosome inhibitor MG132, stabilization of p53 was observed after treatment with either control or Artemis siRNA (Figure 3a ). In addition, the half-life of p53 was increased in U2OS cells treated with Artemis siRNA compared with control siRNA (Supplementary Figure  S2) . Taken together, these results indicate that Artemis depletion causes stabilization of p53 by a post-translational mechanism. This latter finding suggested that Artemis and p53 might physically interact. We, therefore, carried out reciprocal co-immunoprecipitation experiments, and as shown in Figures 3b-d , the results Artemis is a negative regulator of p53 X Zhang et al indicated that Artemis and p53 reside in a common complex. Furthermore, neither the depletion of DNAPKcs nor the inclusion of ethidium bromide affected the interaction between Artemis and p53, indicating that the interaction is not mediated by DNA (Figure 3e ). Taken together, these results suggest that Artemis may directly regulate p53.
Earlier studies from our laboratory and those of others have shown that Artemis is an in vivo substrate of the PIKKs DNA-PKcs, ATM and ATR (Riballo et al., 2004; Zhang et al., 2004; Chen et al., 2005; Wang et al., 2005) . All three of these kinases are also known to phosphorylate p53 in order to mediate its stabilization and activation. In the presence of wortmannin, an inhibitor of all three of these PIKKs (Sarkaria et al., 1998) , stabilization of p53 by Artemis depletion was suppressed (Figure 4a ). We next used siRNA to deplete each of these kinases to determine which one was responsible for the stabilization of p53 upon Artemis depletion. Depletion of ATM did not suppress p53 stabilization after knockdown of Artemis, whereas depletion of DNA-PKcs strongly suppressed this effect (Figure 4b ). Use of a second siRNA directed against DNA-PKcs confirmed this result (data not shown). Simultaneous knockdown of Artemis and ATR led to only a small increase in p53 levels compared with knockdown of ATR alone ( Figure 4c) ; thus, the role of this kinase, if any, is unclear. As Artemis has been implicated in repair of DSBs through nonhomologous end-joining (NHEJ) (Ma et al., 2002; Riballo et al., 2004; Wang et al., 2005) , depletion of Artemis could result in unrepaired DNA damage, and the activation of DNA damage response pathways. However, depletion of Artemis caused neither the phosphorylation of H2AX nor that of Chk2 or Chk1 (Figure 4d ), indicating that unrepaired DNA damage was not the cause of the observed p53 stabilization. This result also affirmed our conclusion that ATM and ATR were not activated by Artemis depletion. As DNA-PKcs was implicated, we next examined whether the heterodimer Ku, the DNA end-binding component of DNA-PK (Meek et al., 2004) , was required for p53 stabilization. Neither Ku70 nor Ku80 suppressed p53 stabilization upon Artemis depletion, indicating that only the catalytic subunit of DNA-PK is involved (Supplementary Figure  S3) . PIKKs are known to phosphorylate p53 at serine residues S15 and S37 to prevent its degradation by E3 ubiquitin ligases (Shieh et al., 1997) . Examination of these two sites showed that both were phosphorylated upon Artemis depletion, and that the concurrent Artemis is a negative regulator of p53 X Zhang et al depletion of DNA-PKcs suppressed this modification (Figure 4e ). Concurrent knockdown of ATM, but not ATR, failed to suppress these modifications (Supplementary Figure S4) ; thus, as indicated above, we cannot exclude a role for ATR in this pathway, although it is clearly not activated for the phosphorylation of Chk1. Finally, mutation of these sites to alanine abrogated the stabilization of p53 upon Artemis depletion (Figure 4f ). Taken together, these findings indicate that Artemis depletion results in the spontaneous phosphorylation (e) Artemis depletion causes phosphorylation of S15 and S37 sites of p53, and these modifications are suppressed by co-depletion of DNA-PKcs. (f) Mutation of S15 or S37 to alanine (S15A, S37A) suppresses the stabilization of p53 by Artemis depletion. Wild-type and mutant p53s were stably expressed in H1299 cells before siRNA-mediated depletion of Artemis.
Artemis is a negative regulator of p53 X Zhang et al and stabilization of p53, and that this process is mediated by DNA-PKcs without a requirement for the Ku heterodimer. Interestingly, phosphorylation at these sites also occurs in HeLa cells after ionizing radiation (data not shown), although stabilization of p53 is not observed (Figure 1c ), suggesting that Artemis depletion results in a separate p53 modification that prevents degradation by the HPV E6-associated ubiquitin ligase.
Mitochondrial oxidative stress induces stabilization of p53 in the absence of Artemis High levels of p53 are known to result in an embryonic lethal phenotype such as is observed in Mdm2 nullizygous mice (Montes de Oca Luna et al., 1995) . However, Artemis nullizygous mice develop normally, except for impaired lymphocyte maturation (Rooney et al., 2002) , suggesting that p53 levels are not abnormally high in these animals. Consistent with this supposition, we examined four tissues from wild-type and Artemis À/À mice and found no differences in p53 expression levels (Supplementary Figure S5A) . Interestingly, however, culturing of Artemis mouse embryonic fibroblasts (MEFs) showed that with increasing passage number, the levels of p53 increased to a much greater extent in nullizygous MEFs compared with wild-type MEFs (Supplementary Figure S5B) . In addition, the nullizygous MEFs exhibited a greater fraction of cells in the G1 phase than did wild-type MEFs, and moreover, stable expression of Artemis in the nullizygous cells greatly reduced the G1 population (Supplementary Figure S6) . Taken together, these findings suggested that culture stress might be the stimulus that induces stabilization of p53 upon Artemis depletion. To examine this hypothesis, we cultured both MEF and MRC5 cells at 3% O 2 , and found that depletion of Artemis no longer induced a strong stabilization of p53 (Figure 5a ). Furthermore, exposing MEFs cultured at 3% O 2 to increasing doses of ionizing radiation did not cause higher stabilization of p53 in Artemis À/À cells, further validating our conclusion that DNA damage is not the stimulus that activates DNA-PKcs in the absence of Artemis (Supplementary Figure S7A) . Hyperoxic conditions produce high levels of intracellular ROS, which could provide the signal for the activation of this pathway; however, treatment of cells cultured at 3% O 2 with hydrogen peroxide (H 2 O 2 ) did not result in differential stabilization of p53 (Supplementary Figure S7B) . Nevertheless, incubation with the antioxidant N-acetyl-L-cysteine (NAC) abrogated the stabilization of p53 induced by Artemis depletion in HeLa and U2OS cells cultured at 21% O 2 , indicating that ROS is, in fact, the stimulus for p53 Artemis is a negative regulator of p53 X Zhang et al accumulation (Figure 5b) . Recently, it has been shown that mitochondrial respiration plays a critical role in the activation of p53 (Karawajew et al., 2005) . This finding combined with our results suggested that ROS produced by mitochondrial respiration might be the source of the signaling stimulus. As a test of this premise, two inhibitors of oxidative phosphorylation, rotenone and thenoyltrifluoroacetone (TTFA), were shown to reduce the stabilization of p53 mediated by Artemis depletion (Figure 5c ). Finally, p53 positively regulates TIGAR and Sestrin 2, two genes involved in reducing ROS (Budanov et al., 2004; Bensaad et al., 2006) . As shown in Figure 5d , Artemis depletion, but not ionizing radiation treatment, caused ROS-dependent upregulation of these two genes. This effect was suppressed by co-depletion of DNA-PKcs (Figure 5e ), indicating that Artemis and DNA-PKcs regulate p53 by a mechanism that is distinct from DNA damage-mediated activation of p53.
Discussion
Our findings indicate that ROS, produced by mitochondrial respiration, provide a signal that activates DNAPKcs to phosphorylate and thereby stabilize p53, which in turn broadly activates genes involved in cellular senescence, apoptosis and regulation of oxidative stress. This pathway is negatively regulated by Artemis, presumably directly as Artemis independently interacts physically with both p53 and DNA-PKcs (Figure 5f ). Thus, Artemis may act as a rheostat to control the degree of activation of p53 in response to oxidative stress. The pathway by which ROS produced by mitochondrial respiration signals to DNA-PKcs is unclear at present. However, ROS have been implicated as second messengers in multiple signaling pathways (Mayer and Noble, 1994; Punj and Chakrabarty, 2003) . Furthermore, redox-regulating oxidoreductases have been shown to function as interacting partners of p53, which indicates the importance of intracellular redoxregulating factors in p53 activation. For example, WOX1, an oxidoreductase, is a proapoptotic protein, which becomes phosphorylated in response to stress or apoptotic stimuli and forms a complex with p53, which subsequently translocates to the mitochondria and further to the nuclei to induce apoptosis (Chang et al., 2003) . In addition, the NQO1 oxidoreductase regulates p53 in an MDM2-independent manner, and is required for the stabilization of p53 (Asher et al., 2001 (Asher et al., , 2002 Anwar et al., 2003) . Finally, ROS-induced stress, created by mitochondrial respiration, has been shown to be directly responsible for the activation of p53 (Karawajew et al., 2005) . Clearly, the full extent of the in vivo implications of this Artemis-regulated p53 pathway will require further investigation.
DNA damage does not seem to contribute to the signaling mechanism as phosphorylation of Chk1, Chk2 and gH2AX was not observed, and there is no requirement for the Ku heterodimer. Recently, it has been shown that direct tethering of DNA-PKcs to chromatin causes activation of its kinase activity in the absence of Ku (Soutoglou and Misteli, 2008) . This finding indicates, as we have shown here, that in certain contexts Ku is not an essential co-factor for DNA-PKcs. We were also able to exclude ATM as a component of this pathway, but were unable to rigorously exclude ATR, although, if it is involved, it is clearly not redundant with DNA-PKcs. Taken together, our findings show a new pathway for the regulation of oxidative stress by DNA-PKcs and p53, and have implications for the processes of aging and tumor suppression. It is interesting that, both hyperoxic and hypoxic conditions, commonly found in tumor microenvironments, lead to the formation of excess ROS from mitochondria (Guzy and Schumacker, 2006) . Artemis is, therefore, a potential target for anticancer therapy as its inhibition in tumors may activate p53, which has been shown to lead to tumor regression (Ventura et al., 2007; Xue et al., 2007) . In fact, observations in mice support such a possibility, as Artemis null mice only exhibit accelerated tumorigenesis in the absence of p53 even though lack of Artemis results in genomic instability (Rooney et al., 2002 (Rooney et al., , 2004 . Thus, in the absence of Artemis, p53 may be more readily activated in response to cellular stress, thereby preventing tumor formation. However, in the absence of both Artemis and p53 increased cellular stress leads to an increased incidence of cancer. These considerations also suggest the possibility that Artemis may function both as a tumor suppressor and as an oncogene. In an overexpressed state Artemis may suppress the activation of p53 and thus promote tumorigenesis; alternatively, its role in the maintenance of genomic stability through its functions in DNA repair and cell-cycle control indicate that it can act as a tumor suppressor.
Materials and methods
Plasmid construction and siRNA Human wild-type p53 cDNA was inserted into pcDNA3.1 at the BamHI and ApaI sites. p53 mutants were prepared using the QuickChange site-directed mutagenesis kit (Stratagene, Cedar Creek, TX, USA). Artemis plasmids were constructed as described earlier (Geng et al., 2007) . Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was used for DNA transfections.
Artemis siRNAs were A1 (5 0 -CUGAAGAGAGCUAGA ACAG-3 0 ); A2 (5 0 -UUAGGAGUCCAGGUUCAUG-3 0 ); A3 (5 0 -GCUGCAAGUUAGUGAAACA-3 0 ); A4 (5 0 -GCAUGG AUGUGAUUCAACA-3 0 ); and A5 (5 0 -CGAGUAACCAGC UCAUAAA-3 0 ). Control, DNAPKcs and ATM siRNA sequences have been described earlier (Zhang et al., 2004; Geng et al., 2007) . Ku80 siRNA (NM-021141) and Ku70 siRNA (SC-29383) were purchased from Dharmacon, Lafayette, CO, USA and Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA respectively. siRNAs were transfected into cells using Oligofectamine or Lipofectamine 2000 reagents (Invitrogen).
Cell culture U2OS (osteosarcoma), HeLa (cervical carcinoma), H1299 (non-small-cell lung carcinoma), HCT-116 (colon carcinoma) and primary fibroblast MRC-5 cells were cultured in DMEM with 10% fetal calf serum. Mouse embryonic fibroblast cells Artemis is a negative regulator of p53 X Zhang et al
